PMD105 - EVALUATING THE COST-EFFECTIVENESS OF SCREENING FOR THE GENETIC RISK OF THROMBOSIS DURING THE RECOMMENDATION OF COMBINED HORMONAL CONTRACEPTION FOR FIRST-TIME USERS IN SWITZERLAND
Abstract
Authors
C.S. Sutherland Z. Ademi J. Michaud N. Schur M. Lingg M. Barbier G. Tanackovic M. Schwenkglenks